Rebecca E. Wolitz retweeted
We're launching an Honors Attorney Program for new and recent law graduates to join the @FTC!
Honors attorneys will work on both antitrust and consumer protection matters. To join the program starting in August 2024, apply by 9/26/23: bit.ly/48gTsEp
Rebecca E. Wolitz retweeted
Folks teaching FDA law - join us Fri for @foodanddruglaw's faculty discussion reintegrating recent caselaw into your class. And oh boy, is there a lot of recent caselaw to contemplate!
(*and* you don't need to be a @foodanddruglaw member for this event)
fdli.org/food-and-drug-law-f…
Rebecca E. Wolitz retweeted
Our #faculty offer so much insight! Professor Wolitz (@REWolitz) was quoted last week in this @BLaw Deep Dive on the #Medicare agency's attempts to adjust their drug price negotiation. Read the full story here: bit.ly/3XElQeV
Rebecca E. Wolitz retweeted
My blog post on the spate of new First Amendment challenges to the federal securities laws:
lawprofessors.typepad.com/bu…
Rebecca E. Wolitz retweeted
Come work with my kind and smart colleagues on AV's drug pricing team!
For more details and to apply, see 👇
arnoldventures.org/careers/h…
Rebecca E. Wolitz retweeted
Join us! @PORTAL_Research @HMSbioethics
This Post is from an account that no longer exists. Learn more
Rebecca E. Wolitz retweeted
ICYMI 👇
I am incredibly fortunate to have been able to work w a team of *incredible* @OSUPublicHealth, @OSU_Law, @osu_pharmacy & @OhioStateMed colleagues--@MicahLBerman, @DonMacarius, @Marty_Fried & @prof_klancaster--on the report discussed in the post & thread below.
This Post is from an account that no longer exists. Learn more
Rebecca E. Wolitz retweeted
Check out my, @eadashi & @CohenProf's latest in @NEJM (& @CohenProf's thread)👇
As we explain, the case could have implications extending far beyond mifepristone, chilling pharmaceutical research & broadly affecting drug regulation & health care.
In short: not good, for anyone.
In @NEJM w/ @pzettler & @eadashi we discuss Alliance for Hippocratic Medicine v. FDA, the case currently pending in the N.D. of Texas claiming that @US_FDA approval of mifepristone was unlawful for pregnancy termination under the Food Drug & Cosmetic Act nejm.org/doi/full/10.1056/NE…
Rebecca E. Wolitz retweeted
The Ohio State Business and Technology Law Journals are proud to present our 2023 joint symposium, Conscious Capitalism: The Role Law Plays in Guiding Corporations to Act Consciously, on Thursday, March 9, 2023.
Rebecca E. Wolitz retweeted
The deadline is approaching! Apply for our Postdoctoral Fellowship.
Deadline: February 28, 2023, at 5:00 PM Pacific time.
👇
Are you interested in legal and social issues arising from advances in the biosciences? Come join us as a Postdoctoral Fellow!
Application Deadline: February 28, 2023, at 5:00 PM Pacific time.
careersearch.stanford.edu/ - Search for job number: 96253.
Rebecca E. Wolitz retweeted
Are you interested in legal and social issues arising from advances in the biosciences? Come join us as a Postdoctoral Fellow!
Application Deadline: February 28, 2023, at 5:00 PM Pacific time.
careersearch.stanford.edu/ - Search for job number: 96253.
Rebecca E. Wolitz retweeted
I wrote about high-priced drugs for years. Then my toddler needed one. It was an *excruciating* lesson in personal futility. But a typical struggle in American health care. washingtonpost.com/wellness/…
Rebecca E. Wolitz retweeted
Do you have a passion for drug pricing and health policy? The folks @CMSGov are looking for talented professionals to help implement the drug pricing components of the IRA! #drugpricing #TwitteRx
Apply now: cms.gov/ira-careers – at Baltimore, MD
Rebecca E. Wolitz retweeted
ICYMI over August vacations, I'm hiring a post-doc in pharma policy, law, and ethics - please spread the word!
🚨📣💊Want to work w/ me, @reshmagar, @cmrherder, @jsross119? Now's your chance! I'm hiring a post-doc in pharma policy, law, and ethics to join me @PennMEHP. Project will examine the feasibility of post-market trials to confirm drug benefit (and more!).
med.upenn.edu/apps/my/bpp_po…
Rebecca E. Wolitz retweeted
🚨📣💊Want to work w/ me, @reshmagar, @cmrherder, @jsross119? Now's your chance! I'm hiring a post-doc in pharma policy, law, and ethics to join me @PennMEHP. Project will examine the feasibility of post-market trials to confirm drug benefit (and more!).
med.upenn.edu/apps/my/bpp_po…
Rebecca E. Wolitz retweeted
This week we are highlighting the #osulaw 2022 Chairs/Professorships. Next up is nationally-recognized health law & bioethics expert Prof. Efthimi Parasidis, Chief Justice Thomas J. Moyer Professorship for the Administration of Justice & Rule of Law. Congrats to Prof. Parasidis!
Rebecca E. Wolitz retweeted
NEW: I wrote about the 200,000 American children orphaned by COVID, and why we’re not on track to prioritize the children who never get to leave the pandemic behind. @TheAtlantic 1/
theatlantic.com/health/archi…
Rebecca E. Wolitz retweeted
(1/4) Cinnamon Carlarne, Assoc. Dean for Faculty & Intellectual Life:
In the field in which I work – environmental and climate change law – women play vital leadership roles. Women are and always have been at the forefront of progressive thinking and action in environmental law.
Rebecca E. Wolitz retweeted
#WomensHistoryMonth faculty feature: Associate Professor @pzettler is on the @foodanddruglaw’s Board of Directors and chairs @ISCTglobal's task force on expanded access to cell and gene therapy. Her research and teaching focus on FDA law/policy, torts, and legislation/regulation.























